Our findings suggest that: i) CSF tau drives cortical plasticity impairment and cognitive decline only in the presence of APOE4 genotype, while APOE3 patients seem to be characterized by other pathological mechanisms; ii) APOE4 patients CSF tau levels can influence astrocytes survival, independently from Aβ levels. The gene discussed is MAPT; the disease is Mental deterioration.